RUA.NZ Rua Bioscience Limited
Company Analysis
Latest News
Rua Bioscience's Rights Offer Falls Flat — Can a Cash-Strapped Cannabis Firm at Three Cents a Share Survive?
Shares of New Zealand medicinal cannabis company Rua Bioscience (RUA.NZ) slid 7.1% to NZ$0.03 after the company disclosed its rights offer raised just NZ$1.0...
🔴 Rua Bioscience is trading 7.14% down today after rights offer raised NZ$1.0m vs NZ$2.8m sought
Rua Bioscience is trading at NZD 0.03, down 7.14%, on October 22; the clearest reported company-specific catalyst is a rights offer that raised approximately...
🔴 Rua Bioscience is trading 7% down today after raising about NZ$1.0m of NZ$2.8m sought
Rua Bioscience is trading 6.67% down at NZD 0.03 after its rights offer raised about NZ$1.0 million, below the NZ$2.8 million sought. - The company said the...
🔴 Rua Bioscience is trading 7% down after rights offer left working-capital shortfall
Rua Bioscience is trading at NZD $0.03 (-6.67%) amid a rights-offer funding shortfall. - The offer raised approximately NZ$1.0 million against NZ$2.8 million...
Rua Bioscience Sends First UK Cannabis Shipment Under NZ$10m Curaleaf Deal
Rua Bioscience has officially named UK medicinal cannabis manufacturer and distributor Curaleaf Laboratories as its partner in a two-year export agreement...
Rua Bioscience Closes Rights Offer to Fund UK Export Deal
Rua Bioscience closed its one-for-three renounceable rights offer on October 15, 2026. The offer sought to raise approximately NZ$2.8 million. The proceeds...
Rua Bioscience Lands a UK Distribution Deal, but Can a Three-Cent Stock Turn Overseas Ambition Into Real Revenue?
Shares of Rua Bioscience ticked up 11.1% to NZD $0.03 after the New Zealand-based medicinal cannabis grower announced a sales and distribution agreement with...
🟢 Rua Bioscience surges 11% on UK distribution agreement with Curaleaf Laboratories
- On October 14, 2026, Rua Bioscience announced a sales and distribution agreement with Curaleaf Laboratories, providing access for its medicinal cannabis...
Rua Secures Exclusive PharmAla MDMA Sales Rights in New Zealand
Rua Bioscience has signed a distribution and licensing agreement with PharmAla Biotech to become the exclusive importer and seller of PharmAla’s...
🔴 Rua Bioscience is trading 7.41% down with no confirmed company-specific catalyst
Rua Bioscience is trading 7.41% down at NZD 0.03, with no confirmed company-specific catalyst identified for October 8, 2026. - NZX shows no company...
🔴 Rua Bioscience is trading 7.4% down with no confirmed catalyst
Rua Bioscience is trading at NZD 0.03, down 7.41%, with the decline unexplained and no verified company-specific catalyst identified. - NZX listings show no...
🟢 Rua Bioscience is trading 8% up
Rua Bioscience is trading at NZD 0.03, up 8.00%, with no verified company-specific event clearly explaining the October 7 move. - A report on its UK...
🟢 Rua Bioscience is trading 12% up
Rua Bioscience is trading 12% up at NZD 0.03; the available information does not establish a specific reason for the move. - A report dated October 6 covered...
🔴 Rua Bioscience is trading 10.71% down; no clear catalyst identified
Rua Bioscience is trading at NZD 0.03, down 10.71%, with no clear company-specific catalyst identified for the October 6 decline. - October 6 reports described...
🔴 Rua Bioscience is trading 10.71% down with no clear catalyst identified
Rua Bioscience is trading 10.71% down at NZD 0.03; no October 6 company announcement or credible report in the searched sources directly explains the...
🔴 Rua Bioscience is trading 9.37% down today after announcing a discounted 1-for-3 rights issue
Rua Bioscience is trading at NZD 0.03, down 9.37%, after announcing a discounted 1-for-3 renounceable rights issue. - The offer seeks to raise up to NZD 2.8...
Rua Bioscience Asks Shareholders for More Cash — Again. Is This Survival or a Slow Bleed?
Shares of New Zealand medicinal cannabis company Rua Bioscience slid 12.5% to NZD 0.03 after the firm announced a deeply discounted rights issue — its third in...
🔴 Rua Bioscience is trading 12.5% down today after announcing a discounted 1-for-3 rights issue
Rua Bioscience is trading at NZD 0.03, down 12.50%, after announcing a 1-for-3 renounceable rights issue priced at NZD 0.025 per share. - The offer seeks up...
🔴 Rua Bioscience is trading 6.25% down today after announcing a discounted renounceable rights issue
Rua Bioscience is trading 6.25% lower at NZ$0.03 after announcing a pro-rata renounceable rights issue priced at NZ$0.025 per share. - The offer price is a 32%...
Rua Bioscience Launches NZ$2.8M Rights Issue, Funding Major UK Export Deal
Rua Bioscience launched a pro-rata renounceable rights issue to raise up to NZ$2.8 million. Existing shareholders in New Zealand and Australia can purchase one...